688336.SS
Price:
$60.14
Market Cap:
$37.09B
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China. Its products include YISAIPU, a tumor necrosis factor inhibitor for rheumatism; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody injection; Cipterbin, an anti-HER2 monoclonal antibody. The company is also developing products for autoimmune diseases, tumors, and other diseases. The company was founded in 2002 and is based in Shanghai, China.
Industry
Biotechnology
IPO Date
2020-07-22
Stock Exchange
SHH
Ticker
688336.SS
According to Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is 42.96. This represents a change of -6.67% compared to the average of 46.03 of the last 4 quarters.
The mean historical PE Ratio of Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd over the last ten years is 131.23. The current 42.96 PE Ratio has changed 3.17% with respect to the historical average. Over the past ten years (40 quarters), 688336.SS's PE Ratio was at its highest in in the March 2022 quarter at 7.98K. The PE Ratio was at its lowest in in the June 2022 quarter at -317.86.
Average
131.23
Median
88.61
Minimum
-69.85
Maximum
632.98
Discovering the peaks and valleys of Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 93.49%
Maximum Annual PE Ratio = 632.98
Minimum Annual Increase = -1006.20%
Minimum Annual PE Ratio = -69.85
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 18.75 | -59.66% |
| 2023 | 46.48 | -70.75% |
| 2022 | 158.90 | -74.90% |
| 2021 | 632.98 | -1006.20% |
| 2020 | -69.85 | -148.04% |
| 2019 | 145.39 | 93.49% |
| 2018 | 75.14 | 5.56% |
| 2017 | 71.18 | -30.26% |
| 2016 | 102.08 | -22.21% |
| 2015 | 131.22 | 0.81% |
The current PE Ratio of Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
74.71
5-year avg
157.45
10-year avg
131.23
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd’s PE Ratio is greater than Shanghai Allist Pharmaceuticals Co., Ltd. (23.39), greater than Pharmaron Beijing Co., Ltd. (34.32), greater than Shanghai RAAS Blood Products Co., Ltd. (23.09), greater than Chongqing Zhifei Biological Products Co., Ltd. (-34.57), greater than RemeGen Co Ltd (-48.85), greater than Shanghai Junshi Biosciences Co., Ltd. (-38.24), greater than Shenzhen New Industries Biomedical Engineering Co., Ltd. (28.10), greater than China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (17.01), greater than Imeik Technology Development Co.,Ltd. (29.99), greater than Beijing Tiantan Biological Products Co., Ltd. (24.70),
| Company | PE Ratio | Market cap |
|---|---|---|
| 23.39 | $46.37B | |
| 34.32 | $43.47B | |
| 23.09 | $42.55B | |
| -34.57 | $46.27B | |
| -48.85 | $44.74B | |
| -38.24 | $35.07B | |
| 28.10 | $46.36B | |
| 17.01 | $47.23B | |
| 29.99 | $43.95B | |
| 24.70 | $32.51B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's PE Ratio?
How is the PE Ratio calculated for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)?
What is the highest PE Ratio for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)?
What is the 3-year average PE Ratio for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)?
What is the 5-year average PE Ratio for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)?
How does the current PE Ratio for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) compare to its historical average?